Does Insurance Cover IV Ketamine Infusions?

Insurance coverage for a treatment generally follows FDA-approved labeling. Spravato (esketamine) is FDA-approved specifically for treatment-resistant depression, which gives insurers a defined indication to build a coverage policy around — typically gated behind prior authorization and documentation of prior antidepressant trials. IV ketamine has no such label for depression: it is approved only as an anesthetic, so its use for depression, anxiety, or PTSD is off-label. [Sanacora 2017] Most insurers categorize off-label psychiatric use as not medically necessary or investigational, and deny coverage on that basis. This is the same distinction covered on our IV ketamine cost page — it is the reason the IV ketamine field runs on cash-pay pricing rather than insurance billing.

Medicare generally does not cover IV ketamine infusions for depression, because the use is off-label; Medicare Advantage plans apply their own medical-necessity criteria and generally reach the same result. Medicaid coverage varies by state, but in most states IV ketamine for mental health conditions is not covered for the same off-label reason. Spravato, by contrast, is covered by Medicare and by Medicaid in a number of states when medical necessity criteria are met — see our Spravato insurance coverage guide for that process. Because plan rules change, treat this as the general pattern and confirm with your own plan.

Even when a plan will not cover IV ketamine directly, some patients with out-of-network mental health benefits can pay for treatment up front and submit an itemized receipt — sometimes called a superbill — to their insurer for partial reimbursement. Whether this works, and how much comes back, depends entirely on your specific plan’s out-of-network benefit structure, and there is no way to predict or guarantee an outcome. If you want to pursue this route, the right first step is calling your insurer directly and asking specifically about out-of-network mental health reimbursement, rather than asking a clinic to guess at your plan’s policy.

One call to the member services number on your card answers more than any general article can:

• Does my plan cover IV ketamine infusions for depression under any circumstances?
• Do I have out-of-network mental health benefits, and what percentage do they reimburse?
• Is there a separate out-of-network deductible, and how much of it have I met?
• What documentation is needed to submit an out-of-network claim, and what is the deadline?
• Is Spravato (esketamine) covered under my plan, and does it require prior authorization?

Ask for a reference number for the call, and note the date and the representative’s name.

The short version: the same FDA-label distinction that makes Spravato insurable makes IV ketamine cash-pay almost everywhere. That is not a clinic policy — it is how coverage works.

The one route worth checking is your own plan’s out-of-network mental health benefit. It takes a phone call, and it is the only way to get an answer that applies to you.